US Broker Ratings

Guardant Health, Inc. (GH) Stock Analysis: High Buy Ratings and Promising Revenue Growth in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH) is garnering significant attention from investors as it continues to make strides in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in..

ADMA Biologics Inc (ADMA) Stock Analysis: Navigating a 72% Potential Upside in the Biotech Sector

ADMA Biologics Inc (NASDAQ: ADMA), a key player in the biotechnology sector, is positioned at the forefront of developing and marketing specialty plasma-derived biologics. With a market capitalization of $4.03..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Navigating Eye Health with a 5.10% Revenue Growth in the Competitive Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO) stands as a significant player in the healthcare sector, specifically within the medical instruments and supplies industry. With its headquarters in Vaughan, Canada, Bausch..

Hologic, Inc. (HOLX) Stock Analysis: Navigating a 10.65% Upside Potential in the Healthcare Sector

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, stands out for its comprehensive portfolio in medical instruments and supplies. With a market capitalization of $14.85 billion, Hologic..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a 33.96% Potential Upside in Healthcare Tech

Waystar Holding Corp. (NASDAQ: WAY) is capturing the attention of investors with its robust position in the healthcare technology sector. Specializing in cloud-based software solutions for healthcare payments, Waystar is..

Krystal Biotech, Inc. (KRYS) Investor Outlook: Navigating the 36.55% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is capturing investor attention with its impressive potential upside of 36.55%, as indicated by current analyst ratings. This Pittsburgh-based biotechnology company, with a market capitalization..

Alkermes plc (ALKS) Stock Analysis: Navigating a 39% Potential Upside in Biopharma Innovation

Alkermes plc (NASDAQ: ALKS), a prominent player in the biopharmaceutical sector, offers investors a compelling opportunity with a potential upside of 39.1%. Headquartered in Dublin, Ireland, the company is renowned..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a Potential 33.75% Upside for Investors

HealthEquity, Inc. (HQY) stands out in the healthcare sector, specifically within the health information services industry. With a market capitalization of $7.88 billion, this Utah-based company has carved a niche..

The Cigna Group (CI) Investor Outlook: Exploring a Robust Upside Potential of 20.90%

Investors keen on healthcare stocks may find The Cigna Group (NYSE: CI) an intriguing prospect as it demonstrates a promising potential upside of 20.90%, according to current analyst ratings. With..

Revvity, Inc. (RVTY) Stock Analysis: Unveiling a 34.83% Upside Potential in Healthcare Diagnostics

Revvity, Inc. (NYSE: RVTY) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $10.06 billion, this U.S.-based company..

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: A Biotech with 10% Potential Upside and Promising Drug Pipeline

Rhythm Pharmaceuticals, Inc. (RYTM), a key player in the biotechnology sector, is making waves with its focus on rare neuroendocrine diseases. The company, headquartered in Boston, Massachusetts, has been capturing..

Novartis AG (NVS) Investor Outlook: Evaluating Growth Potential Despite Current Valuation Concerns

Novartis AG (NVS), a titan in the global healthcare sector, operates primarily in the drug manufacturing industry. Headquartered in Basel, Switzerland, the company is renowned for its extensive portfolio, including..

McKesson Corporation (MCK) Stock Analysis: A Healthcare Giant with a Promising 14.72% Upside

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, is a name synonymous with medical distribution in the United States and internationally. With a robust market capitalization of $85.5..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 31.73% Potential Upside

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, particularly in the medical devices industry, presents a compelling opportunity for investors seeking growth potential. With a market..

Chemed Corp (CHE) Stock Analysis: 25% Upside Potential Amidst Strong Performance Metrics

Chemed Corp (CHE), a key player in the healthcare sector, specifically in the medical care facilities industry, presents an intriguing investment opportunity with its current market dynamics suggesting a significant..

Doximity, Inc. (DOCS) Stock Analysis: Navigating Growth in Health Information Services

Doximity, Inc. (NYSE: DOCS) is making waves in the healthcare sector with its innovative digital platform tailored for medical professionals. As the company continues to gain traction, it presents a..

BioNTech SE (BNTX) Stock Analysis: Exploring Growth Potential with a 21% Upside

BioNTech SE (NASDAQ: BNTX), a leading biotechnology company headquartered in Mainz, Germany, has been a focal point for investors interested in the healthcare sector, particularly in the field of immunotherapies...

Encompass Health Corporation (EHC) Investor Outlook: Strong Buy Ratings Signal Potential Upside

Encompass Health Corporation (NYSE: EHC) stands out in the healthcare sector, particularly within the medical care facilities industry, with a robust market capitalization of $12.65 billion. Based in Birmingham, Alabama,..

Koninklijke Philips N.V. (PHG) Stock Analysis: Unlocking a 17.32% Potential Upside in Healthcare Innovation

Koninklijke Philips N.V. (NYSE: PHG), a stalwart in the healthcare sector, is drawing attention from investors as it embarks on a transformative journey within the medical devices industry. With a..

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 27% Potential Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH), a prominent player in the healthcare sector, is capturing investor interest with its current valuation and potential upside. With a market capitalization of $3.2..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds